Inhibitors of 125I-epidermal growth factor internalization.
D000098:Acetophenones / Q000494:pharmacology*; D000818:Animals; D001391:Azo Compounds / Q000494:pharmacology; D001414:Bacitracin / Q000494:pharmacology; D002478:Cells, Cultured; D002746:Chlorpromazine / Q000494:pharmacology; D004705:Endocytosis / Q000187:drug effects*; D004815:Epidermal Growth Factor / Q000037:antagonists & inhibitors*; D008744:Methylamines / Q000494:pharmacology; D010455:Peptides / Q000037:antagonists & inhibitors*; D010658:Phenylglyoxal / Q000494:pharmacology; D010740:Phospholipases / Q000037:antagonists & inhibitors*; D010741:Phospholipases A / Q000037:antagonists & inhibitors*; D011796:Quinacrine / Q000494:pharmacology; D051381:Rats
D000098:Acetophenones; D001391:Azo Compounds; D008744:Methylamines; D010455:Peptides; D001414:Bacitracin; D004815:Epidermal Growth Factor; D010740:Phospholipases; D010741:Phospholipases A; D011796:Quinacrine; D010658:Phenylglyoxal; C006821:4-bromophenacyl bromide; D002746:Chlorpromazine